Cytotoxic T-lymphocyte antigen 4 and programmed cell death ligand 1 blockade increases the effectiveness of interleukin-15 immunotherapy in a bovine leukemia model
Kanatbek Mukantayev , Kanat Tursunov , Zhansaya Adish , Darkhan Kanayev , Laura Tokhtarova , Malika Nurtleu , Bisultan Abirbekov
See more
1
Laboratory of Immunochemistry and Immunobiotechnology, National Center for Biotechnology, 010000, Astana, Kazakhstan.
2
Laboratory of Immunochemistry and Immunobiotechnology, National Center for Biotechnology, 010000, Astana, Kazakhstan.
3
Laboratory of Immunochemistry and Immunobiotechnology, National Center for Biotechnology, 010000, Astana, Kazakhstan; Department of Natural Sciences, L.N. Gumilyov Eurasian National University, 010008, Astana, Kazakhstan. .
4
Laboratory of Immunochemistry and Immunobiotechnology, National Center for Biotechnology, 010000, Astana, Kazakhstan.
5
Laboratory of Immunochemistry and Immunobiotechnology, National Center for Biotechnology, 010000, Astana, Kazakhstan.
6
Laboratory of Immunochemistry and Immunobiotechnology, National Center for Biotechnology, 010000, Astana, Kazakhstan.
7
Laboratory of Immunochemistry and Immunobiotechnology, National Center for Biotechnology, 010000, Astana, Kazakhstan.
Corresponding Author:
Kanat Tursunov (kanat_tka@mail.ru)
Mukantayev et al. This article is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License.
